TrialBritish journal of haematology2026
Daratumumab plus bortezomib and dexamethasone (Dara-VD) in newly diagnosed Mayo 2004 stage IIIA and IIIB light-chain amyloidosis: Long-term follow-up results from a prospective phase 2 study.
Gao Xue-Min et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.